Logo image of ACCB.BR

ACCENTIS NV (ACCB.BR) Stock Fundamental Analysis

EBR:ACCB - Euronext Brussels - BE0003696102 - Common Stock - Currency: EUR

0.031  0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ACCB. ACCB was compared to 73 industry peers in the Real Estate Management & Development industry. ACCB scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACCB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ACCB had negative earnings in the past year.
ACCB had a positive operating cash flow in the past year.
ACCB had positive earnings in each of the past 5 years.
In the past 5 years ACCB always reported a positive cash flow from operatings.
ACCB.BR Yearly Net Income VS EBIT VS OCF VS FCFACCB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

ACCB has a better Return On Assets (1.34%) than 63.01% of its industry peers.
The Return On Equity of ACCB (1.99%) is better than 60.27% of its industry peers.
With an excellent Return On Invested Capital value of 5.08%, ACCB belongs to the best of the industry, outperforming 89.04% of the companies in the same industry.
ACCB had an Average Return On Invested Capital over the past 3 years of 5.02%. This is in line with the industry average of 3.86%.
The 3 year average ROIC (5.02%) for ACCB is below the current ROIC(5.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.34%
ROE 1.99%
ROIC 5.08%
ROA(3y)2.11%
ROA(5y)5.04%
ROE(3y)3.24%
ROE(5y)7.24%
ROIC(3y)5.02%
ROIC(5y)5.52%
ACCB.BR Yearly ROA, ROE, ROICACCB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 12.21%, ACCB is in the better half of the industry, outperforming 68.49% of the companies in the same industry.
In the last couple of years the Profit Margin of ACCB has declined.
ACCB's Operating Margin of 61.89% is amongst the best of the industry. ACCB outperforms 86.30% of its industry peers.
In the last couple of years the Operating Margin of ACCB has grown nicely.
The Gross Margin of ACCB (63.14%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ACCB has grown nicely.
Industry RankSector Rank
OM 61.89%
PM (TTM) 12.21%
GM 63.14%
OM growth 3Y5.47%
OM growth 5Y6.36%
PM growth 3Y-46.84%
PM growth 5Y-21.08%
GM growth 3Y6.19%
GM growth 5Y6.82%
ACCB.BR Yearly Profit, Operating, Gross MarginsACCB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACCB is destroying value.
The number of shares outstanding for ACCB remains at a similar level compared to 1 year ago.
ACCB has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ACCB has been reduced compared to a year ago.
ACCB.BR Yearly Shares OutstandingACCB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ACCB.BR Yearly Total Debt VS Total AssetsACCB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 2.27 indicates that ACCB is not a great score, but indicates only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.27, ACCB belongs to the best of the industry, outperforming 87.67% of the companies in the same industry.
ACCB has a debt to FCF ratio of 3.25. This is a good value and a sign of high solvency as ACCB would need 3.25 years to pay back of all of its debts.
ACCB has a better Debt to FCF ratio (3.25) than 94.52% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that ACCB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.28, ACCB is in the better half of the industry, outperforming 76.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 3.25
Altman-Z 2.27
ROIC/WACC0.73
WACC6.91%
ACCB.BR Yearly LT Debt VS Equity VS FCFACCB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

ACCB has a Current Ratio of 5.89. This indicates that ACCB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ACCB (5.89) is better than 87.67% of its industry peers.
A Quick Ratio of 5.89 indicates that ACCB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.89, ACCB belongs to the best of the industry, outperforming 90.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.89
Quick Ratio 5.89
ACCB.BR Yearly Current Assets VS Current LiabilitesACCB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

0

3. Growth

3.1 Past

ACCB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.43%.
ACCB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -37.32% yearly.
ACCB shows a decrease in Revenue. In the last year, the revenue decreased by -8.56%.
ACCB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.23% yearly.
EPS 1Y (TTM)-71.43%
EPS 3Y-64.58%
EPS 5Y-37.32%
EPS Q2Q%-83.33%
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y-32.73%
Revenue growth 5Y-20.23%
Sales Q2Q%-2.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACCB.BR Yearly Revenue VS EstimatesACCB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ACCB.BR Price Earnings VS Forward Price EarningsACCB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ACCB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ACCB is cheaper than 73.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.94
EV/EBITDA N/A
ACCB.BR Per share dataACCB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.01 0.02 0.03

4.3 Compensation for Growth

The decent profitability rating of ACCB may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACCB!.
Industry RankSector Rank
Dividend Yield N/A

ACCENTIS NV

EBR:ACCB (6/4/2025, 7:00:00 PM)

0.031

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap39.15M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.14
P/FCF 9.94
P/OCF 9.94
P/B 1
P/tB 1
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY10.06%
OCF(TTM)0
OCFY10.06%
SpS0.01
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 1.99%
ROCE 7.2%
ROIC 5.08%
ROICexc 7.6%
ROICexgc 7.6%
OM 61.89%
PM (TTM) 12.21%
GM 63.14%
FCFM 61.75%
ROA(3y)2.11%
ROA(5y)5.04%
ROE(3y)3.24%
ROE(5y)7.24%
ROIC(3y)5.02%
ROIC(5y)5.52%
ROICexc(3y)7.03%
ROICexc(5y)8.49%
ROICexgc(3y)7.03%
ROICexgc(5y)8.49%
ROCE(3y)7.13%
ROCE(5y)7.8%
ROICexcg growth 3Y-21.44%
ROICexcg growth 5Y9.05%
ROICexc growth 3Y-21.44%
ROICexc growth 5Y9.05%
OM growth 3Y5.47%
OM growth 5Y6.36%
PM growth 3Y-46.84%
PM growth 5Y-21.08%
GM growth 3Y6.19%
GM growth 5Y6.82%
F-Score6
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 3.25
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0%
Interest Coverage 4.75
Cash Conversion N/A
Profit Quality 505.65%
Current Ratio 5.89
Quick Ratio 5.89
Altman-Z 2.27
F-Score6
WACC6.91%
ROIC/WACC0.73
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.15%
Cap/Sales(5y)N/A
Profit Quality(3y)477.54%
Profit Quality(5y)330.92%
High Growth Momentum
Growth
EPS 1Y (TTM)-71.43%
EPS 3Y-64.58%
EPS 5Y-37.32%
EPS Q2Q%-83.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y-32.73%
Revenue growth 5Y-20.23%
Sales Q2Q%-2.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.88%
EBIT growth 3Y-29.05%
EBIT growth 5Y-15.15%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.72%
FCF growth 3Y0.58%
FCF growth 5Y-11.58%
OCF growth 1Y20.57%
OCF growth 3Y0.56%
OCF growth 5Y-11.58%